Vault-13

GENERAL ATLANTIC, L.P.

New York, NY · CIK 1017645 · 13F filing filed 2024-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$3.2bn reported value -26.1% vs Q1 2024
19positions
94.2%in top 10
0 new 0 added 2 reduced 3 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 XP INC CL A XP XP 29,617,733 $521.0m16.38% 16.38% UnchangedShares held: Q3 2023 29.6m, Q4 2023 29.6m, Q1 2024 29.6m, Q2 2024 29.6m
2 DLOCAL LTD CLASS A COM DLO DLO 63,906,695 $517.0m16.26% 16.26% UnchangedShares held: Q3 2023 63.9m, Q4 2023 63.9m, Q1 2024 63.9m, Q2 2024 63.9m
3 ALKAMI TECHNOLOGY INC COM ALKT ALKT 17,186,985 $489.5m15.39% 15.39% ReducedShares held: Q3 2023 18.7m, Q4 2023 18.7m, Q1 2024 18.7m, Q2 2024 17.2m -1.5m -1,542,821 -8.2%
4 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 60,993,323 $477.0m15.00% 15.00% UnchangedShares held: Q3 2023 61.0m, Q4 2023 61.0m, Q1 2024 61.0m, Q2 2024 61.0m
5 SQUARESPACE INC CLASS A SQSP SQSP 10,611,073 $463.0m14.56% 14.56% UnchangedShares held: Q3 2023 16.6m, Q4 2023 10.6m, Q1 2024 10.6m, Q2 2024 10.6m
6 PHARVARIS N V COM PHVS PHVS 7,531,252 $141.6m4.45% 4.45% UnchangedShares held: Q3 2023 4.4m, Q4 2023 6.2m, Q1 2024 7.5m, Q2 2024 7.5m
7 EUROPEAN WAX CTR INC CLASS A COM EWCZ EWCZ 13,110,492 $130.2m4.09% 4.09% UnchangedShares held: Q3 2023 13.1m, Q4 2023 13.1m, Q1 2024 13.1m, Q2 2024 13.1m
8 AKERO THERAPEUTICS INC COM AKRO AKRO 5,233,989 $122.8m3.86% 3.86% UnchangedShares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 5.2m, Q2 2024 5.2m
9 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 9,681,818 $87.4m2.75% 2.75% UnchangedShares held: Q3 2023 9.7m, Q4 2023 9.7m, Q1 2024 9.7m, Q2 2024 9.7m
10 BLEND LABS INC CL A BLND BLND 19,132,440 $45.2m1.42% 1.42% UnchangedShares held: Q3 2023 19.1m, Q4 2023 19.1m, Q1 2024 19.1m, Q2 2024 19.1m
11 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 1,261,684 $42.8m1.34% 1.34% ReducedShares held: Q3 2023 950.0k, Q4 2023 950.0k, Q1 2024 1.5m, Q2 2024 1.3m -245.0k -245,000 -16.3%
12 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 1,500,000 $39.6m1.24% 1.24% UnchangedShares held: Q3 2023 1.5m, Q4 2023 1.5m, Q1 2024 1.5m, Q2 2024 1.5m
13 THIRD HARMONIC BIO INC COM COM 2,958,762 $38.5m1.21% 1.21% UnchangedShares held: Q3 2023 3.0m, Q4 2023 3.0m, Q1 2024 3.0m, Q2 2024 3.0m
14 RISKIFIED LTD SHS CL A RSKD RSKD 5,324,998 $34.0m1.07% 1.07% UnchangedShares held: Q3 2023 5.3m, Q4 2023 5.3m, Q1 2024 5.3m, Q2 2024 5.3m
15 ACELYRIN INC COM COM 2,889,668 $12.7m0.40% 0.40% UnchangedShares held: Q3 2023 2.9m, Q4 2023 2.9m, Q1 2024 2.9m, Q2 2024 2.9m
16 OPENDOOR TECHNOLOGIES INC COM OPEN OPEN 6,321,519 $11.6m0.37% 0.37% UnchangedShares held: Q3 2023 6.3m, Q4 2023 6.3m, Q1 2024 6.3m, Q2 2024 6.3m
17 CONTEXTLOGIC INC CL A NEW LOGC LOGC 609,616 $3.5m0.11% 0.11% UnchangedShares held: Q3 2023 609.6k, Q4 2023 609.6k, Q1 2024 609.6k, Q2 2024 609.6k
18 GROVE COLLABORATIVE HOLD INC COM CL A GROV GROV 936,020 $1.7m0.05% 0.05% UnchangedShares held: Q3 2023 936.0k, Q4 2023 936.0k, Q1 2024 936.0k, Q2 2024 936.0k
19 ADAGENE INC ADS ADAG ADAG 264,000 $807.8k0.03% 0.03% UnchangedShares held: Q3 2023 264.0k, Q4 2023 264.0k, Q1 2024 264.0k, Q2 2024 264.0k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
HIRERIGHT HOLDINGS CORPORATI 32,109,898 $458.2m32.1m shares
HUTCHMED CHINA LTD HCM HCM 4,000,000 $67.2m4.0m shares
MOBILEYE GLOBAL INC MBLY MBLY 1,194,839 $38.4m1.2m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
DLOCAL LTD DLO · 13D · filed 2026-08-19 DLO 21.4%≈ $478.4m -6.9 pts 13D 2026-08-19
ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 ALKT 18.1%≈ $351.9m +1.8 pts 13D 2026-05-15
LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 LFTO 15.0%≈ $608.1m new 13D 2026-06-12
SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 SPTX 11.5%≈ $132.5m new 13D 2026-05-11
AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 AKRO 8.4% 13G 2025-05-15
PHARVARIS N V PHVS · 13G · filed 2026-08-14 PHVS 7.6%≈ $185.3m 13G 2026-08-14
CHIME FINL INC CHYM · 13G · filed 2025-11-10 CHYM 5.6%≈ $393.4m new 13G 2025-11-10
XP INC XP · 13D · filed 2025-12-04 XP 5.4%≈ $370.1m 13D 2025-12-04

Trades reported as a company insider in Q2 2024

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2024-05-07 ALKAMI TECHNOLOGY INC Director · See footnote ALKT Sold 1,542,821 $40.9m1.5m shares -8%